labetalol has been researched along with Bleeding in 2 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"In a model of uncontrolled hemorrhagic hypotension (UCHH) in rats, we examined whether blood loss or blood chemistry were affected by (1) deliberate, controlled hypotension induced with labetalol (L) or sodium nitroprusside (SNP) and (2) intravenous (iv) fluid therapy." | 7.70 | Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage. ( Artru, AA; Geva, D; Gurevich, B; Gurman, G; Shapira, Y, 1998) |
"In a model of uncontrolled hemorrhagic hypotension (UCHH) in rats, we examined whether blood loss or blood chemistry were affected by (1) deliberate, controlled hypotension induced with labetalol (L) or sodium nitroprusside (SNP) and (2) intravenous (iv) fluid therapy." | 3.70 | Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage. ( Artru, AA; Geva, D; Gurevich, B; Gurman, G; Shapira, Y, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gurevich, B | 1 |
Artru, AA | 1 |
Geva, D | 1 |
Gurman, G | 1 |
Shapira, Y | 1 |
McNulty, S | 1 |
Sharifi-Azad, S | 1 |
Farole, A | 1 |
2 other studies available for labetalol and Bleeding
Article | Year |
---|---|
Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage.
Topics: Animals; Antihypertensive Agents; Combined Modality Therapy; Evaluation Studies as Topic; Fluid Ther | 1998 |
Induced hypotension with labetalol for orthognathic surgery.
Topics: Hemoglobins; Hemorrhage; Humans; Hypotension, Controlled; Injections, Intravenous; Jaw Diseases; Lab | 1987 |